# Zonisamide Outpatient Study

> **NCT03376139** · PHASE2 · WITHDRAWN · sponsor: **Pharmacotherapies for Alcohol and Substance Use Disorders Alliance**

## Conditions studied

- Post Traumatic Stress Disorder
- Alcohol Use Disorder

## Interventions

- **DRUG:** Zonisamide
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT03376139
- **Lead sponsor:** Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-03-01
- **Primary completion:** 2019-08-31
- **Final completion:** 2019-08-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Futility
- **Last updated:** 2021-03-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03376139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03376139, "Zonisamide Outpatient Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03376139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*